Modified vaccinia virus Ankara protects macaques against respiratory challenge with monkeypox virus. - Wikidata - wikimedia - TriplyDB

Modified vaccinia virus Ankara protects macaques against respiratory challenge with monkeypox virus.

Modified vaccinia virus Ankara protects macaques against respiratory challenge with monkeypox virus.

http://www.wikidata.org/entity/Q33843163

about

Smallpox vaccines for biodefense: need and feasibility The evolution of poxvirus vaccines Human Monkeypox Development of eczema vaccinatum in atopic mouse models and efficacy of MVA vaccination against lethal poxviral infection Side-by-side comparison of gene-based smallpox vaccine with MVA in nonhuman primates Modeling the Effect of Herd Immunity and Contagiousness in Mitigating a Smallpox Outbreak.Antiviral treatment is more effective than smallpox vaccination upon lethal monkeypox virus infection.A protein-based smallpox vaccine protects mice from vaccinia and ectromelia virus challenges when given as a prime and single boost.A novel highly reproducible and lethal nonhuman primate model for orthopox virus infection Application of the Ibis-T5000 pan-Orthopoxvirus assay to quantitatively detect monkeypox viral loads in clinical specimens from macaques experimentally infected with aerosolized monkeypox virus.A randomized, double-blind, dose-finding Phase II study to evaluate immunogenicity and safety of the third generation smallpox vaccine candidate IMVAMUNE.Experimental infection of cynomolgus macaques (Macaca fascicularis) with aerosolized monkeypox virus.Combinations of polyclonal or monoclonal antibodies to proteins of the outer membranes of the two infectious forms of vaccinia virus protect mice against a lethal respiratory challenge A protein-based smallpox vaccine protects non-human primates from a lethal monkeypox virus challenge.Smallpox vaccine with integrated IL-15 demonstrates enhanced in vivo viral clearance in immunodeficient mice and confers long term protection against a lethal monkeypox challenge in cynomolgus monkeys.Long term recall of memory CD8 T cells in mice to first and third generation smallpox vaccines.Poxvirus antigen staining of immune cells as a biomarker to predict disease outcome in monkeypox and cowpox virus infection in non-human primates Genomic sequence and virulence of clonal isolates of vaccinia virus Tiantan, the Chinese smallpox vaccine strain.Comparative analysis of monkeypox virus infection of cynomolgus macaques by the intravenous or intrabronchial inoculation route.Smallpox vaccines: targets of protective immunity.Comparative live bioluminescence imaging of monkeypox virus dissemination in a wild-derived inbred mouse (Mus musculus castaneus) and outbred African dormouse (Graphiurus kelleni).Deletion of the A35 gene from Modified Vaccinia Virus Ankara increases immunogenicity and isotype switching IMVAMUNE: modified vaccinia Ankara strain as an attenuated smallpox vaccine.Expression of CCL20 and granulocyte-macrophage colony-stimulating factor, but not Flt3-L, from modified vaccinia virus ankara enhances antiviral cellular and humoral immune responses.Deletion of major nonessential genomic regions in the vaccinia virus Lister strain enhances attenuation without altering vaccine efficacy in mice.Development of the small-molecule antiviral ST-246 as a smallpox therapeutic.Cowpox virus infection of cynomolgus macaques as a model of hemorrhagic smallpox.Deletion of the monkeypox virus inhibitor of complement enzymes locus impacts the adaptive immune response to monkeypox virus in a nonhuman primate model of infection Development of ST-246® for Treatment of Poxvirus Infections.Evaluation of monkeypox disease progression by molecular imaging Small particle aerosol inoculation of cowpox Brighton Red in rhesus monkeys results in a severe respiratory disease.Measurement of antibody responses to Modified Vaccinia virus Ankara (MVA) and Dryvax(®) using proteome microarrays and development of recombinant protein ELISAs Sequence of pathogenic events in cynomolgus macaques infected with aerosolized monkeypox virus.Susceptibility of Marmosets (Callithrix jacchus) to Monkeypox Virus: A Low Dose Prospective Model for Monkeypox and Smallpox Disease.Structural and Functional Characterization of Anti-A33 Antibodies Reveal a Potent Cross-Species Orthopoxviruses Neutralizer.A Multicenter, Open-Label, Controlled Phase II Study to Evaluate Safety and Immunogenicity of MVA Smallpox Vaccine (IMVAMUNE) in 18-40 Year Old Subjects with Diagnosed Atopic Dermatitis.Vaccinia Virus LC16m8∆ as a Vaccine Vector for Clinical Applications.Safety, immunogenicity and efficacy of modified vaccinia Ankara (MVA) against Dryvax challenge in vaccinia-naïve and vaccinia-immune individuals.Percutaneous Vaccination as an Effective Method of Delivery of MVA and MVA-Vectored Vaccines Development of smallpox vaccine candidates with integrated interleukin-15 that demonstrate superior immunogenicity, efficacy, and safety in mice

P2860

Q22305942-5246E0D2-B9A1-4FE5-8BEC-81AC1054D039 Q26995905-1B3B23A9-1241-4A05-B877-92E4A2903DA9 Q27023061-77E13878-84E1-44DB-A2A7-44F3B2D0A8EC Q27321985-00B9C286-E652-4878-8897-62AE9279696E Q27325586-E69BBF87-41EA-4BD9-93F8-56F7E3C8EC8D Q30205740-5E91D496-BF8A-4D6E-8DAA-692749C073A8 Q30231576-1CC46BA9-926A-4B42-AA3E-AF7A524C6EF0 Q30445071-F3890FBC-5805-47FF-8D6E-158BB907A54D Q33573571-9CEAC5AD-5DDB-439A-9F39-EB44BD97E7C2 Q33617625-B6CF2487-8B6B-447D-83ED-3D1FB11645F6 Q33624420-FF5BFD07-758B-45ED-B32A-54672B373C1D Q33700318-5349A774-EFDC-4E66-BBD5-5092944B973F Q34092845-C8DEC2BC-DC94-4EA8-ADFB-368F8A600BE7 Q34126697-29C9EDA3-A6D0-4A70-A103-FFE53502C0D4 Q34188464-8679D468-6A99-4029-9A1E-4B9B76029772 Q34556632-C7B189D6-27F4-4544-89EE-3C9458BBC520 Q34663791-88E83839-E73C-4583-B6C7-67C8E2307FFC Q34673390-E5A84B2B-887D-4AFB-9BF9-235542ED889B Q34742139-FB0B9D1C-847A-4656-A853-0F060A6629FB Q34780607-96CDA25F-B91A-40EE-BCCD-28B2C0B9C30D Q34791242-12A6FE94-8544-473A-86F4-307DE2927E01 Q34810232-E3B8670D-A560-437C-ADE2-90410432DC97 Q34907430-52004037-706E-41AE-88B9-38BB430BC9E3 Q35023778-E31EFBDC-B080-443F-9CDD-6F6A86F77C8C Q35076706-11F072F3-B191-468B-9EB7-28128936F98A Q35152092-F46D0938-6635-48B5-A0C2-584E9676A8A8 Q35189550-91110C08-EF84-4362-87D3-9AC16F2235BE Q35192707-94E4A8AF-84C8-41D3-9CF4-86DA05138A25 Q35260385-00F1F6E3-96C3-45F5-BC03-23A7BC20744E Q35532858-BE07A317-390E-4C8E-BB98-9A1C656E2A0A Q35578840-76E3B4C2-C769-4CA9-83D4-ECF86D27B71D Q35634159-92681D66-B062-45C4-9D51-E2FB5AA55938 Q35640911-C22BC8AF-AD13-41E2-86B8-105952E3E17D Q35683735-E02A6662-8C60-41F7-8E7A-583055B531DD Q35760869-FD1C8927-1A81-4774-B9BA-A1ECC993640F Q35800226-A6F2BDEC-25EE-435C-9193-DF721B872EF5 Q35826728-605487B9-B093-4D6B-81FD-BD91C31DF42C Q35844057-D41A7F43-81F3-4C53-A1CD-0C4E3502314F Q35928588-2A9115E2-A5D4-48B8-80D2-F8A1AE77CB6C Q35947780-6E13EF87-7AF6-40C5-A2BA-E3803100D7EF

P2860

Modified vaccinia virus Ankara protects macaques against respiratory challenge with monkeypox virus.

http://www.wikidata.org/entity/Q33843163

description

2005 nî lūn-bûn

@nan

2005 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Modified vaccinia virus Ankara ...... hallenge with monkeypox virus.

@en

type

label

Modified vaccinia virus Ankara ...... hallenge with monkeypox virus.

@en

prefLabel

Modified vaccinia virus Ankara ...... hallenge with monkeypox virus.

@en

P1433

Q33843163-B54C015C-29C6-4648-AA3D-7B505FDDAE32

P1476

Q33843163-0EF5F0CF-158D-4F61-8738-9DED6A66E21C

P2093

Q33843163-0DEA041A-4AD9-4AE2-B3E7-04EF8E835417

Q33843163-1CB18AB1-9E06-45B4-BF63-8693E98E3A3E

Q33843163-21AAEC93-CA36-4285-93A4-4730E7BFD279

Q33843163-465D35A4-3869-40E8-A5C5-8FB678B37412

Q33843163-948EC7E0-7008-450F-BD9F-72F2E17C6322

Q33843163-BB4645CB-4294-4A5B-A595-906F2EE82207

Q33843163-CECA305E-33A8-4BE8-933D-B0DA6E8999A2

Q33843163-D9C748B1-0223-490B-B6A5-79FC13A4BCF7

Q33843163-E3365A9F-1E53-4C5A-AB28-857FE7453BA3

Q33843163-FD1654EE-C849-4ECD-BAEC-070557C31332

P2860

Q33843163-086DE040-BCA7-425F-A234-2657374206C2

Q33843163-28E99368-716B-4780-9FC9-6306415F6623

Q33843163-2F1698D0-B388-42DB-ADEC-1A9C1CFE98DB

Q33843163-34D6FDE3-E19C-45FF-9316-3108AE5AD661

Q33843163-3AA43813-E588-4FB4-B6A1-06A6980E9C56

Q33843163-3CFE470D-CF5B-40A2-B280-5151BF1ABBFE

Q33843163-564FB75E-D07E-4AA6-A6D1-FB34D640695B

Q33843163-56B91436-F4B1-41FE-BCFC-9BBEFCDEEC05

Q33843163-577078D7-6519-481D-860F-C69F95521F01

Q33843163-651F6E8E-6001-4541-8038-EC8389DB9201

P304

Q33843163-708CCF92-017A-45D5-B652-D8A14BC3778D

P31

Q33843163-4A239578-9C59-40EA-BC9A-5CACECD07699

P356

Q33843163-267068B2-16F0-4F3B-B43C-25331458B027

P433

Q33843163-F02927DF-C8D6-491A-ACCE-74671400347A

P478

Q33843163-F9748557-3338-407A-B707-877D160F0F85

P50

Q33843163-52440504-20C4-4F2C-BF9E-AC176BAF761E

Q33843163-E1710EF7-AFB9-4103-870D-7E1C6C9700FA

P577

Q33843163-8128184C-8044-48BA-9213-10BBCA42805E

P5875

Q33843163-69F3E0E6-E688-44DA-B3CC-282E3BBA5288

P698

Q33843163-4258AA33-7AA4-42DD-A09D-A8EA3B178E1F

P932

Q33843163-5DF83BC0-1E13-437F-A684-02D0EBB07161

P356

JVI.79.12.7845-7851.2005

P1433

Journal of Virology

P1476

Modified vaccinia virus Ankara ...... hallenge with monkeypox virus.

@en

P2093

Ben A M van der Zeijst

http://www.w3.org/2001/XMLSchema#string

Frank H M Pistoor

http://www.w3.org/2001/XMLSchema#string

Geert van Amerongen

http://www.w3.org/2001/XMLSchema#string

Gerard van Doornum

http://www.w3.org/2001/XMLSchema#string

Hubert G M Niesters

http://www.w3.org/2001/XMLSchema#string

Ivanela Kondova

http://www.w3.org/2001/XMLSchema#string

Koert J Stittelaar

http://www.w3.org/2001/XMLSchema#string

Luis Mateo

http://www.w3.org/2001/XMLSchema#string

Paul J Chaplin

http://www.w3.org/2001/XMLSchema#string

Rob F van Lavieren

http://www.w3.org/2001/XMLSchema#string

P2860

Smallpox as a Biological Weapon

Outbreaks of disease suspected of being due to human monkeypox virus infection in the Democratic Republic of Congo in 2001.

Protective immunity in macaques vaccinated with a modified vaccinia virus Ankara-based measles virus vaccine in the presence of passively acquired antibodies.

Clinical virology in real time.

Development of vaccines for bio-warfare agents.

Progressive vaccinia.

Smallpox vaccination and bioterrorism with pox viruses.

Separate worlds set to collide: smallpox, vaccinia virus vaccination, and human immunodeficiency virus and acquired immunodeficiency syndrome.

Zoonotic poxvirus infections in humans.

Nonreplicating vaccinia vector efficiently expresses recombinant genes.

P304

7845-7851

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.79.12.7845-7851.2005

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

79

http://www.w3.org/2001/XMLSchema#string

P50

P577

2005-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7821774

http://www.w3.org/2001/XMLSchema#string

P698

15919938

http://www.w3.org/2001/XMLSchema#string

P932

1143678

http://www.w3.org/2001/XMLSchema#string